David D. Saggau

Reproducibility of Spectral-Domain Optical Coherence Tomography Retinal Thickness Measurements and Conversion to Equivalent Time-Domain Metrics in Diabetic Macular Edema

Susan B. Bressler, Allison R. Edwards, K V Chalam et al. · JAMA Ophthalmology · 2014 · 104 citations · Full text

Health Professions, Ophthalmology, Vision Science +17

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

Lee M. Jampol, Adam R. Glassman, Danni Liu et al. · Ophthalmology · 2018 · 44 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12

INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO OCULAR HISTOPLASMOSIS SYNDROME

Jared S. Nielsen, Tyler A. Fick, David D. Saggau et al. · Retina · 2011 · 29 citations

Medicine, Ophthalmology, Ocular Disease +11

RIFAMPIN INDUCED HEPATOTOXICITY DURING TREATMENT FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Joel W. Nelson, David D. Saggau, Jared S. Nielsen · Retinal Cases & Brief Reports · 2013 · 18 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

High-Dose Aflibercept for Neovascular AMD and DME in Suboptimal Responders to Standard-Dose Aflibercept

Jared S. Nielsen, Carter L. Roberts, David D. Saggau et al. · Journal of VitreoRetinal Diseases · 2023 · 13 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17